Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PDZK1 encodes a PDZ domain-containing scaffolding protein. Additionally we are shipping PDZK1 Proteins (6) and PDZK1 Kits (4) and many more products for this protein.
Showing 10 out of 123 products:
Cow (Bovine) Polyclonal PDZK1 Primary Antibody for ICC, IF - ABIN152917
Lan, Silver: Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1. in The Journal of biological chemistry 2005
Show all 4 Pubmed References
Human Monoclonal PDZK1 Primary Antibody for IHC (p) - ABIN2476097
Walker, MacLeod, Williams, Cameron, Smyth, Langdon: Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. in Gynecologic oncology 2007
These findings have provided first lines of evidences that PDZK1 expression is negatively correlated with SHP-1 activation and poor clinical outcomes in clear cell renal cell carcinoma (ccRCC) . PDZK1 was identified as a novel tumor suppressor in ccRCC by negating SHP-1 activity
HNF1alpha (show HNF1A Antibodies), which has previously been described as a modulator of several transporters of the renal transportosome, is also a key determinant of PDZK1 transcription.
a PDZK1 single nucleotide polymorphism rs12129861 was found to be significantly associated with gout susceptibility (meta-analysis)
PDZK1 was defined as an independent prognostic factor for both OS and DFS (show FST Antibodies). These findings indicated that low level of PDZK1 could predict poor clinical outcome in patients with ccRCC.
Inflammation-induced loss of PDZK1 expression may contribute to the NHE3 (show SLC9A3 Antibodies) dysfunction observed in the inflamed intestine.
PARP (show COL11A2 Antibodies) regulates estradiol-mediated cell growth by controlling the ER/IGF-1R (show IGF1R Antibodies)/PDZK1 axis.
PDZK1, negatively regulates 5-HT2AR endocytosis and has no effect upon 5-HT2AR-mediated ERK1/2 (show MAPK1/3 Antibodies) phosphorylation.
Described is a structure of D-AKAP2 (show AKAP10 Antibodies) in complex with two interacting partners and the exact mechanism by which a segment that on its own is disordered presents an alpha-helix to PKA and a beta (show SUCLA2 Antibodies)-strand to PDZK1.
PDZK1 and NHERF1 regulate the transport function of OATP1A2 by modulating protein internalization via a clathrin-dependent pathway and by enhancing protein stability.
Correlation between PDZK1, Cdc37 (show CDC37 Antibodies), Akt (show AKT1 Antibodies) and breast cancer malignancy: the role of PDZK1 in cell growth through Akt (show AKT1 Antibodies) stabilization by increasing and interacting with Cdc37 (show CDC37 Antibodies)
PDZK1 has novel SR-BI (show SCARB1 Antibodies)-independent function in VSM that affords protection from neointima formation, and this involves PDZK1 suppression of VSM cell proliferation via an inhibitory interaction with Bcr (show BCR Antibodies)
Data show that interaction of the inducible nitric oxide synthase (iNOS (show NOS2 Antibodies)) C-terminus with the PDZ (show INADL Antibodies) domains of EBP50 (show SLC9A3R1 Antibodies) protein or Pdzk1 protein CAP70 resulted greater nitric oxide (NO) synthesis.
PDZK1 regulates intracellular trafficking of Oatp1a1 (show Slco1a1 Antibodies).
PDZK1(NHERF3) is entirely non-raft associated with lipid rafts in brush border membrane fractions of NHE3 (show SLC9A3 Antibodies).
NHERF3 is a key regulator of organic transport in the kidney, particularly MRP4-mediated clearance of drug molecules.
SR-BI (show SCARB1 Antibodies) and PDZK1 protein and mRNA expression levels fell rapidly in primary hepatocyte cultures, indicating this system does not adequately mimic hepatocytes in vivo for analysis of the PDZK1 dependence of SR-BI (show SCARB1 Antibodies).
the localization of PDZK1 on hepatocyte cell surface membranes in vivo is dependent on its PDZ4 domain and the presence of SR-BI (show SCARB1 Antibodies).
The impairment of the absorptive function of the inflamed colon in the IL-10 (show IL10 Antibodies)(-/-) mouse, in spite of unaltered NHE3 (show SLC9A3 Antibodies) expression and localization, is accompanied by the downregulation of the NHE3 (show SLC9A3 Antibodies)-regulatory PDZ (show INADL Antibodies) adaptors NHERF2 (show SLC9A3R2 Antibodies) and PDZK1.
PDZK1 plays a pivotal role in the apical localization of BCRP (show ABCG2 Antibodies).
This gene encodes a PDZ domain-containing scaffolding protein. PDZ domain-containing molecules bind to and mediate the subcellular localization of target proteins. The encoded protein mediates the localization of cell surface proteins and plays a critical role in cholesterol metabolism by regulating the HDL receptor, scavenger receptor class B type 1. Single nucleotide polymorphisms in this gene may be associated with metabolic syndrome, and overexpression of this gene may play a role in drug resistance of multiple myeloma. Pseudogenes of this gene are located on the long arm of chromosome 1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
PDZ domain containing 1
, Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like
, CFTR-associated protein of 70 kDa
, Na(+)/H(+) exchange regulatory cofactor NHE-RF3
, PDZ-containing kidney protein 1
, na/Pi cotransporter C-terminal-associated protein 1
, sodium-hydrogen exchanger regulatory factor 3
, Na(+)/H(+) exchanger regulatory factor 3
, PDZ domain-containing protein 1
, PDZK1-like protein
, C-terminal linking and modulating protein
, C-terminal-linking and modulating protein
, dietary Pi-regulated RNA-1